Jamie Brunner

Jamie Brunner serves as a Contracting Officer responsible for managing complex procurements within the federal acquisition system, with a specialized focus on medical and laboratory products and services. In this role, she ensures compliance with federal regulations under the FAR and implements acquisition strategies that align with agency mission needs, particularly in health-related technical domains. Her portfolio primarily encompasses contracts for diagnostic substances, surgical supplies, and medical laboratory services, requiring deep technical understanding of product specifications, regulatory pathways, and performance-based acquisition methods. She exercises full contracting authority from solicitation through award and administration, ensuring transparency, competition, and accountability in every phase of the procurement lifecycle. While specific contractor names are not available, Jamie Brunner maintains relationships with a diverse range of vendors, including large manufacturers of medical devices and in-vitro diagnostic systems, as well as small businesses capable of delivering specialized laboratory and surgical support services. Her contracting approach emphasizes competitive bidding, clear performance metrics, and vendor accountability, fostering long-term partnerships built on reliability and regulatory compliance. She actively engages with industry through pre-solicitation outreach and market research to ensure acquisition strategies reflect current technological capabilities and supply chain realities. Jamie Brunner demonstrates a strong preference for open competition, with 91.1% of her acquisitions conducted without set-asides. However, she consistently supports small business participation, allocating 7.1% of awards to Total Small Business Set-Asides under FAR 19.5 and 1.8% to 8(a) competed contracts. This pattern reflects a balanced approach—prioritizing broad competition while intentionally creating pathways for socioeconomically disadvantaged businesses to compete for federal contracts. Her primary procurement focus lies in NAICS codes 325413 (In-Vitro Diagnostic Substance Manufacturing), 339113 (Surgical Appliance and Supplies Manufacturing), and 621511 (Medical Laboratories), indicating deep expertise in procuring diagnostic reagents, sterile surgical tools, and clinical testing services. She is well-versed in the regulatory and technical requirements governing medical device and laboratory supply acquisitions, ensuring all procurements meet FDA, CLIA, and other applicable standards.